TY - JOUR
T1 - HLA class I–associated expansion of TRBV11-2 T cells in multisystem inflammatory syndrome in children
AU - Porritt, Rebecca A.
AU - Paschold, Lisa
AU - Rivas, Magali Noval
AU - Cheng, Mary Hongying
AU - Yonker, Lael M.
AU - Chandnani, Harsha
AU - Lopez, Merrick
AU - Simnica, Donjete
AU - Schultheiß, Christoph
AU - Santiskulvong, Chintda
AU - Van Eyk, Jennifer
AU - McCormick, John K.
AU - Fasano, Alessio
AU - Bahar, Ivet
AU - Binder, Mascha
AU - Arditi, Moshe
N1 - Publisher Copyright:
© 2021, American Society for Clinical Investigation.
PY - 2021/5
Y1 - 2021/5
N2 - Multisystem inflammatory syndrome in children (MIS-C), a hyperinflammatory syndrome associated with SARS-CoV-2 infection, shares clinical features with toxic shock syndrome, which is triggered by bacterial superantigens. Superantigen specificity for different Vβ chains results in Vβ skewing, whereby T cells with specific Vβ chains and diverse antigen specificity are overrepresented in the T cell receptor (TCR) repertoire. Here, we characterized the TCR repertoire of MIS-C patients and found a profound expansion of TCRβ variable gene 11-2 (TRBV11-2), with up to 24% of clonal T cell space occupied by TRBV11-2 T cells, which correlated with MIS-C severity and serum cytokine levels. Analysis of TRBJ gene usage and complementarity-determining region 3 (CDR3) length distribution of MIS-C expanded TRBV11-2 clones revealed extensive junctional diversity. Patients with TRBV11-2 expansion shared HLA class I alleles A02, B35, and C04, indicating what we believe is a novel mechanism for CDR3-independent T cell expansion. In silico modeling indicated that polyacidic residues in the Vβ chain encoded by TRBV11-2 (Vβ21.3) strongly interact with the superantigen-like motif of SARS-CoV-2 spike glycoprotein, suggesting that unprocessed SARS-CoV-2 spike may directly mediate TRBV11-2 expansion. Overall, our data indicate that a CDR3-independent interaction between SARS-CoV-2 spike and TCR leads to T cell expansion and possibly activation, which may account for the clinical presentation of MIS-C.
AB - Multisystem inflammatory syndrome in children (MIS-C), a hyperinflammatory syndrome associated with SARS-CoV-2 infection, shares clinical features with toxic shock syndrome, which is triggered by bacterial superantigens. Superantigen specificity for different Vβ chains results in Vβ skewing, whereby T cells with specific Vβ chains and diverse antigen specificity are overrepresented in the T cell receptor (TCR) repertoire. Here, we characterized the TCR repertoire of MIS-C patients and found a profound expansion of TCRβ variable gene 11-2 (TRBV11-2), with up to 24% of clonal T cell space occupied by TRBV11-2 T cells, which correlated with MIS-C severity and serum cytokine levels. Analysis of TRBJ gene usage and complementarity-determining region 3 (CDR3) length distribution of MIS-C expanded TRBV11-2 clones revealed extensive junctional diversity. Patients with TRBV11-2 expansion shared HLA class I alleles A02, B35, and C04, indicating what we believe is a novel mechanism for CDR3-independent T cell expansion. In silico modeling indicated that polyacidic residues in the Vβ chain encoded by TRBV11-2 (Vβ21.3) strongly interact with the superantigen-like motif of SARS-CoV-2 spike glycoprotein, suggesting that unprocessed SARS-CoV-2 spike may directly mediate TRBV11-2 expansion. Overall, our data indicate that a CDR3-independent interaction between SARS-CoV-2 spike and TCR leads to T cell expansion and possibly activation, which may account for the clinical presentation of MIS-C.
KW - Systemic Inflammatory Response Syndrome/genetics
KW - Complementarity Determining Regions/genetics
KW - SARS-CoV-2/genetics
KW - T-Lymphocytes/immunology
KW - Receptors, Antigen, T-Cell, alpha-beta/genetics
KW - Humans
KW - COVID-19/genetics
KW - Female
KW - Histocompatibility Antigens Class I/genetics
KW - Male
KW - Child
KW - Spike Glycoprotein, Coronavirus/genetics
UR - https://www.scopus.com/pages/publications/85106664700
UR - https://www.scopus.com/pages/publications/85106664700#tab=citedBy
UR - https://www.mendeley.com/catalogue/b0a7062c-d0ef-3588-94d4-ded17dc17945/
U2 - 10.1172/JCI146614
DO - 10.1172/JCI146614
M3 - Article
C2 - 33705359
SN - 0021-9738
VL - 131
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 10
M1 - e146614
ER -